Physician profile
William Harris
NPI 1013103100
$202,508.30
in general payments reported to CMS, 2019-2025
49 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,098 · 2020: $3,493 · 2021: $9,748 · 2022: $1,255 · 2023: $1,934 · 2024: $46K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $179K · Food and Beverage: $5,029 · Travel and Lodging: $21.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $178,862.86 |
| Food and Beverage | $5,029.14 |
| Travel and Lodging | $21.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $180,317.37 | 2023-2025 | |
| Organogenesis INC. | $11,525.04 | 2019-2023 | Puraply |
| Crossroads Extremity Systems, LLC | $3,054.88 | 2019 | |
| Peerless Surgical INC. | $1,456.26 | 2019-2025 | |
| Intelivation Technologies, LLC | $750.00 | 2021 | |
| Imbed Biosciences INC. | $602.25 | 2023 | |
| Stryker Corporation | $501.33 | 2019-2025 | Citrefix, Hoffmann, Axsos |
| Kerecis Limited | $492.39 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Triad Life Sciences INC. | $481.95 | 2022 | |
| Smith+Nephew, INC. | $303.80 | 2019-2024 | Grafix Pl, Collagenase Santyl, Regranex |
| Paragon 28, INC. | $240.99 | 2024 | Monkey Rings |
| Koya Medical, INC. | $221.15 | 2022-2025 | Dayspring, Koya Medical |
| Depuy Synthes Sales INC. | $215.46 | 2022-2025 | Motoband |
| Amgen INC. | $212.48 | 2024-2025 | Krystexxa |
| Arthrex, INC. | $189.60 | 2020 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $184.47 | 2022-2025 | |
| Reddress USA, INC. | $179.70 | 2025 | Actigraft |
| Horizon Therapeutics Plc | $156.07 | 2019-2023 | Krystexxa |
| Progenacare Global, LLC | $133.76 | 2023 | |
| Next Science LLC | $131.94 | 2023-2024 | Surgx, Blastx, Xperience |
| Bone Support INC. | $131.43 | 2024 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $121.29 | 2023-2025 | Nuzyra |
| Kuros Biosciences USA, INC | $103.40 | 2023 | |
| Davol INC. | $92.44 | 2020-2025 | Arista |
| Baudax Bio INC. | $61.33 | 2020 | |
| Nevro Corp. | $59.36 | 2022-2023 | Senza |
| Royal Biologics, INC. | $53.47 | 2025 | |
| Mimedx Group, INC. | $45.02 | 2024-2025 | |
| Hartmann USA, INC. | $36.92 | 2021 | |
| Bioventus LLC | $35.72 | 2024 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $30.17 | 2019-2020 | |
| Hydrofera LLC | $29.95 | 2022 | |
| Polarityte, INC. | $29.61 | 2019 | |
| Integra Lifesciences Corporation | $27.97 | 2019 | |
| Grt US Holding, INC. | $27.53 | 2020 | |
| Abbvie INC. | $27.11 | 2023 | |
| Atland Pharmaceuticals, LLC | $26.26 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Acelrx Pharmaceuticals, INC. | $25.06 | 2020 | |
| Solventum Corporation | $23.41 | 2025 | Activ.A.C. |
| Boston Scientific Corporation | $23.13 | 2024 | |
| Averitas Pharma INC. | $23.13 | 2023 | Qutenza |
| Nabriva Therapeutics, Plc | $19.70 | 2021 | |
| Advanced Oxygen Therapy INC. | $18.73 | 2024 | Topical Oxygen Chamber For Extremities |
| Melinta Therapeutics, LLC | $17.97 | 2019 | |
| United Orthopedics LLC | $17.68 | 2023 | |
| Sebela Pharmaceuticals INC. | $13.88 | 2023 | Naftin |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.81 | 2021 | |
| Ossio INC | $12.40 | 2022 | |
| Checkpoint Surgical, INC | $9.53 | 2024 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.